Surviving Lymphoma: The Clinical Trial Approach

On October 12^th at 1:00pm EST for a featured event: Surviving Lymphoma-The Clinical Trial Approach, featuring stories on the importance of clinical trials, personal experiences from survivors, and how Massive Bio’s AI has helped champion the clinical trial journey for thousands of patients.

Surviving Lymphoma was hosted on the Massive Bio Facebook page, with our medical experts, as well as testimonials from lymphoma survivors, about the success of cancer patients participating in clinical trials. With Massive Bio’s help, finding a clinical trial doesn’t have to be difficult. Massive Bio utilizes our state-of-the-art AI technology to find you the best fitting clinical trial close to home. Jackie Bement, patient relations coordinator was joined by Laurie Adami and Mary Kent, who are both lymphoma patients that enrolled in clinical trials and then later were declared in remission.

During this live discussion, we will also take questions directly from the community and discuss all you could want to know about lymphoma and clinical trials, ending the session with a live Q&A featuring Kristin Johnston, Chief Nursing Officer at Massive Bio.

The event aired on Tuesday, October 12^th at 1:00pm EST. Watch the full video of the event below.

Lymphoma is a cancer that starts in the cells that are part of the body’s immune system and can begin in lymph nodes in many parts of the body. Clinical trials offer the possibility of receiving a brand-new therapy that is still in the approval process by the FDA. For some patients, clinical trials may offer treatment options where none previously existed. For other patients, clinical trials may offer a more targeted approach to treating their diseases than the currently accepted, approved standards of care.

Join our live event to learn more about lymphoma clinical trials and more! Taking part in a clinical trial may be the best option for some lymphoma patients. What is best for you?